An LC–MS/MS method for steroid profiling during adrenal venous sampling for investigation of primary aldosteronism

Author(s):  
Mirko Peitzsch ◽  
Tanja Dekkers ◽  
Matthias Haase ◽  
Fred C.G.J. Sweep ◽  
Ivo Quack ◽  
...  
2020 ◽  
Vol 52 (06) ◽  
pp. 373-378 ◽  
Author(s):  
Taweesak Wannachalee ◽  
Adina F. Turcu

AbstractAdrenal venous sampling is the standard of care for identifying patients with unilateral primary aldosteronism, which is often caused by an aldosterone producing adenoma and can be cured with surgery. The numerous limitations of adrenal venous sampling, including its high cost, scarce availability, technical challenges, and lack of standardized protocols, have driven efforts to develop alternative, non-invasive tools for the diagnosis of aldosterone producing adenomas. Seminal discoveries regarding the pathogenesis of aldosterone producing adenomas made over the past decade have leveraged hypotheses-driven research of steroid phenotypes characteristic of various aldosterone producing adenomas. In parallel, the expanding availability of mass spectrometry has enabled the simultaneous quantitation of many steroids in single assays from small volume biosamples. Steroid profiling has contributed to our evolving understanding about the pathophysiology of primary aldosteronism and its subtypes. Herein, we review the current state of knowledge regarding the application of multi-steroid panels in assisting with primary aldosteronism subtyping.


2019 ◽  
Vol 34 (1) ◽  
pp. 34-42 ◽  
Author(s):  
Yuichi Fujii ◽  
◽  
Yoshiyu Takeda ◽  
Isao Kurihara ◽  
Hiroshi Itoh ◽  
...  

2011 ◽  
pp. P2-604-P2-604
Author(s):  
Akiyo Tanabe ◽  
Mika Tsuiki ◽  
Aya Tsumagari ◽  
Hitomi Kimura ◽  
Mitsuhide Naruse ◽  
...  

2021 ◽  
Author(s):  
Filippo Crimì ◽  
Alessandro Spimpolo ◽  
Diego Cecchin ◽  
Gian Paolo Rossi

Soinio et al. recently compared the diagnostic accuracy of 11C-metomidate PET (11C-MTO-PET) and cosyntropin-stimulated adrenal venous sampling (AVS) for the subtyping of patients with primary aldosteronism (PA), who were diagnosed according to the 2008 Endocrine Society guidelines. They concluded that 11C-MTO-PET offered no diagnostic usefulness in subtyping of PA patients. In our view, this conclusion needs to be taken with great caution owing to a number of concerns that can be raised concerning their study


2016 ◽  
Vol 6 (1) ◽  
Author(s):  
Chin-Chen Chang ◽  
Bo-Ching Lee ◽  
Kao-Lang Liu ◽  
Yeun-Chung Chang ◽  
Vin-Cent Wu ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document